A research group led by Professor Wei Li of Faculty of Pharmaceutical Sciences, Toho University, in international collaboration with Shenyang Pharmaceutical University in China, Duke University Medical Center and University of North Carolina Eshelman School of Pharmacy in the United States, discovered for the first time that Wikstroemia lamatsoensis contains a substance inhibiting replication of human immunodeficiency virus (HIV).
It is expected that further research could potentially lead to the discovery of new drugs with superior anti-HIV activity for HIV treatment. These results were published on August 17, 2021 in the Journal of Natural Products, a journal of the American Chemical Society. The result was selected as the cover illustration for the issue.
Figure 1. LC-MS guided isolation of anti-HIV tigliane diterpenoids from Wikstroemia lamatsoensis.
RESEARCH
– News
– Guidelines & Policies
– Support Offices
– Facilities
– Security Export Control
Non-Degree Programs
– Clinical Elective Program
– International Physician Observership Program